44.201.94.72
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Lupus Nephritis

Clinically meaningful ORR to zetomipzomib seen in patients with lupus nephritis

Positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN) were announced by Kezar Life Sciences, Inc, in a press release. In this phase 2 clinical trial open-label study, patients with LN were treated with 60 mg of zetomipzomib subcutaneously once...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-